Received Jan 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
coccidioidomycosis; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COCCIDIOIDOMYCOSIS (hospitalization), outcome "not recovered". Clinical course: The patient was in the hospital at the time of the report with coccidioidomycosis and stated it was from Pfizer COVID-19 Vaccine. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.